Bharat Biotech’s Covaxin Shows 77.8% Efficacy in Phase 3 Trial Data

Posted on by

Covaxin’s Phase 3 trial data which has shown 77.8% efficacy was approved by the Subject Expert Committee (SEC) under DCGI on Tuesday.